Regeneron Pharmaceuticals, Inc. (REGN) News Today: Latest Market and Industry Updates
790.99
5.3500
0.67 %
At close
10/16
USD
Daily range
787.62
802.46
802.46
Weekly range
744.15
808.37
808.37
Regeneron Pharmaceuticals receives EMA committee approval for alternative immunotherapy dosing after stock ends session up 2.2%
Regeneron Pharmaceuticals said the European Medicines Agency's CHMP recommended approval of an alternative dosing regimen for its immunotherapy in approved cancer uses. The stock is up 2.2% on the ...
REGN drops as seller pressure builds near $710.46 support
Regeneron Pharmaceuticals (REGN) stock is trading at $732.58 after a 3.36% decline on the day. The price is currently positioned below its key moving averages, ...
Regeneron shares technical analysis: Support test at $742.65
Regeneron (REGN) stock is trading at $754.35, down 4.28% for the session. The price sits below its key moving averages, indicating notable short-term and medium-term ...
Why is Regeneron Pharmaceuticals stock down 3.4% today?
Selling pressure dominated Regeneron Pharmaceuticals, Inc. (REGN) on a sharp 3.4% drop as downside momentum took hold in the absence of fresh news catalysts. The move is supported by REGN trading ...
Regeneron Pharmaceuticals stock outlook: Strong buying pressure fuels advance after sharp rally
Regeneron Pharmaceuticals (REGN) stock is trading at $852.4, up 3.47% on the day. The price is positioned above its key moving averages, reflecting strong upward ...
What's behind Regeneron Pharmaceuticals' latest 3.4% stock surge?
Regeneron Pharmaceuticals, Inc. (REGN) surged 3.42% after stronger than expected earnings and major manufacturing expansion announcements drove buyer interest. The up move is further supported by ...
Regeneron Pharmaceuticals stock rally: Price targets to watch
Regeneron Pharmaceuticals (REGN) stock is trading at $822.97, up 2.99% on the day. The price currently sits above its key moving averages, with short- and medium-term ...
Regeneron Pharmaceuticals shares technical analysis: Buyer support could drive further rally
Regeneron Pharmaceuticals (REGN) stock is trading at $761.64 after advancing 3.19% for the day. The price holds above its key moving averages, reflecting sustained ...
Regeneron surges 6.15% to $738.21 as Regeneron spotlights 2026 innovation prize winners
Regeneron Pharmaceuticals announced the winners of the 2026 Regeneron Prize for Creative Innovation. The company recognized early-career scientists for their bold 'dream project' proposals in ...
Regeneron Pharmaceuticals stock edges higher to $696.55 as Q2 2026 results are posted, Regeneron announces
Regeneron Pharmaceuticals announced its second quarter 2026 financial and operating results. The company reported a strong quarter.Regeneron Pharmaceuticals cited pipeline progress and commercial ...
Phase 3 trial for Fianlimab and Libtayo fails: REGN technical outlook
Regeneron (REGN) stock is trading at $650.72, marking a daily decline of 3.56%. The price remains positioned below its key moving averages, indicating persistent selling ...
Regeneron Pharmaceuticals shares gain over 4% as technical momentum and upside gap attract buyers
Regeneron Pharmaceuticals, Inc. (REGN) jumped 4.03% today as strong technical momentum and a decisive upside gap fueled buying interest. However, the move appears limited with price action ...
Buying pressure lifts Regeneron Pharmaceuticals stock higher in today's trading
Regeneron Pharmaceuticals, Inc. (REGN) gained 2.54% today amid a firm intraday tone and technical buying, with prices holding above the 20-day moving average. The up move is limited, as the stock ...
FDA and EMA accept Regeneron's myasthenia gravis therapy filings
Regeneron Pharmaceuticals announced that the U.S. FDA and EMA have accepted regulatory submissions for review of its novel siRNA investigational medicine for adult patients with generalized ...
What is behind Regeneron Pharmaceuticals stock's recent gain in value today
Regeneron Pharmaceuticals, Inc. (REGN) closed at $616.40 after rising 2.73% for the session. The stock trades below all major moving averages, highlighting ongoing downward pressure across short-, ...
Regeneron Pharmaceuticals stock price forecast: $588.98 support in focus as REGN slides 3.86%
Regeneron Pharmaceuticals (REGN) stock is trading at $611.01 after losing 3.86% on the day, underperforming across key moving averages on a pronounced sell-off and ...
Regeneron Pharmaceuticals shares dip amid rising selling pressure
Regeneron Pharmaceuticals (REGN) is trading well below its 20-day, 50-day, and 200-day simple moving averages, with the current price at $603.04 compared to $675.81, $719.37, and $694.72 ...
Regeneron Pharmaceuticals stock consolidates as Global Capability Centre opening in Hyderabad draws focus
Regeneron Pharmaceuticals (REGN) stock is trading at $639.22, posting a minimal daily gain of 0.09%. The price remains well below its key moving averages, indicating it ...
